Fortis Healthcare Limited (NSE:FORTIS)
India · Delayed Price · Currency is INR 766.60
-7.95 (-1.03%)
Nov 11, 2026, 1:55 PM IST
Fortis Healthcare Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Fortis Healthcare stock has a consensus rating of "Strong Buy" and an average price target of ₹1,045. The average 1-year stock price forecast is 36.34% higher than the current stock price, while the lowest is ₹810.00 (+5.66%) and the highest is ₹1,180 (+53.93%).
Price Target: ₹1,045 (+36.34%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 11, 2026.
Analyst Ratings
The average analyst rating for Fortis Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 14 | 16 | 16 | 16 | 15 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹1,180 | Buy | Maintains | ₹1,180 | +53.93% | Aug 11, 2026 |
| Geojit Research | Geojit Research | Buy Reiterates ₹1,150 | Buy | Reiterates | ₹1,150 | +50.01% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
107.50B
from 91.28B
Increased by 17.77%
Revenue Next Year
123.68B
from 107.50B
Increased by 15.05%
EPS This Year
16.45
from 14.03
Increased by 17.27%
EPS Next Year
21.94
from 16.45
Increased by 33.34%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.